<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04170764</url>
  </required_header>
  <id_info>
    <org_study_id>19-111</org_study_id>
    <nct_id>NCT04170764</nct_id>
  </id_info>
  <brief_title>Clinical Utility of Postoperative Hemoglobin Testing</brief_title>
  <official_title>Clinical Utility of Postoperative Hemoglobin Testing Following Vaginal Hysterectomy and Reconstruction for Symptomatic Pelvic Organ Prolapse</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TriHealth Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TriHealth Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate how many patients have hemoglobin less than 10 g/dL&#xD;
      at post-operative day 1.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obtaining a complete blood count (CBC) on post-operative day 1 to assess postoperative&#xD;
      hemoglobin levels is routine practice at Cincinnati Urogynecology Associates, TriHealth Inc.&#xD;
      after pelvic reconstructive surgery.&#xD;
&#xD;
      There is minimal data supporting this practice. Multiple studies throughout the gynecology&#xD;
      literature suggest that this is not a necessary or cost effective strategy to assess for&#xD;
      postoperative anemia. Most patients who require blood transfusion or reoperation for bleeding&#xD;
      will show clinical signs of anemia.&#xD;
&#xD;
      The investigators aim to determine if checking a routine CBC results in clinically relevant&#xD;
      changes to patient care in women undergoing pelvic reconstructive surgery with vaginal&#xD;
      hysterectomy for treatment of pelvic organ prolapse.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 22, 2019</start_date>
  <completion_date type="Actual">May 28, 2020</completion_date>
  <primary_completion_date type="Actual">May 19, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of subjects with hemoglobin less than 10 g/dL</measure>
    <time_frame>Postop Day 1</time_frame>
    <description>Number of subjects with hemoglobin less than 10 g/dL following Vaginal Hysterectomy and Reconstruction for Symptomatic Pelvic Organ Prolapse</description>
  </primary_outcome>
  <enrollment type="Actual">664</enrollment>
  <condition>Anaemia Postoperative</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All patients who underwent a total vaginal hysterectomy with concurrent vaginal native&#xD;
        tissue prolapse repairs performed by one of four fellowship trained urogynecologists at&#xD;
        TriHealth between 10/1/2014 and 10/1/2019. The patients will be identified by CPT codes in&#xD;
        the EPIC electronic medical record.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Total vaginal hysterectomy with or without bilateral salpingectomy/oophorectomy (CPT&#xD;
             58260, 58262, 58263, 58270, 58290, 58291, 58292, 58294)&#xD;
&#xD;
          -  At least one of the following vaginal native tissue prolapse repairs&#xD;
&#xD;
               -  Apical repair with uterosacral ligament suspension (CPT 57283)&#xD;
&#xD;
               -  Apical repair with sacrospinous ligament fixation (CPT 57282)&#xD;
&#xD;
               -  Anterior repair (CPT 57240, 57260, 57284, 57285, 57250)&#xD;
&#xD;
               -  Posterior repair (CPT 45560, 56800, 56810, 57200, 57210, 57250)&#xD;
&#xD;
          -  Surgery by one of four fellowship trained urogynecologists at TriHealth&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Concomitant surgical procedure by a second surgeon&#xD;
&#xD;
          -  Malignancy identified at the time of surgery or active malignancy&#xD;
&#xD;
          -  Cases converted to open hysterectomy or prolapse repairs&#xD;
&#xD;
          -  Prolapse repair completed robotically&#xD;
&#xD;
          -  Prolapse repair completed with mesh&#xD;
&#xD;
          -  Known coagulopathy&#xD;
&#xD;
          -  Patient on long term preoperative anticoagulant medication (Arixtra, Coumadin,&#xD;
             Eliquis, Heparin, Lovenox, Pradaxa, Savaysa, Xarelto)&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rachel Pauls, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>TriHealth - Cincinnati Urogynecology Associates</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cincinnati Urogynecology Associates</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>November 18, 2019</study_first_submitted>
  <study_first_submitted_qc>November 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 20, 2019</study_first_posted>
  <last_update_submitted>February 24, 2021</last_update_submitted>
  <last_update_submitted_qc>February 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

